Concomitant BET and MAPK blockade for effective treatment of ovarian cancer
Ying Jing(The University of Texas Health Science Center at Houston), Guanglei Zhuang(Shanghai Jiao Tong University)
Cited by 34
Related Papers
Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway
|The EMBO Journal|2012|471
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
|Nature Communications|2020|206
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
|Nature Communications|2018|153
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
|Theranostics|2015|100
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer
|Nature Communications|2017|78